JP2011515391A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011515391A5 JP2011515391A5 JP2011500740A JP2011500740A JP2011515391A5 JP 2011515391 A5 JP2011515391 A5 JP 2011515391A5 JP 2011500740 A JP2011500740 A JP 2011500740A JP 2011500740 A JP2011500740 A JP 2011500740A JP 2011515391 A5 JP2011515391 A5 JP 2011515391A5
- Authority
- JP
- Japan
- Prior art keywords
- oxidase
- hydrogen peroxide
- producing enzyme
- medicament
- medicament according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims 18
- 239000003814 drug Substances 0.000 claims 12
- 108090000790 Enzymes Proteins 0.000 claims 10
- 102000004190 Enzymes Human genes 0.000 claims 10
- 229940088598 enzyme Drugs 0.000 claims 10
- 108010015776 Glucose oxidase Proteins 0.000 claims 5
- 239000004366 Glucose oxidase Substances 0.000 claims 5
- 229940116332 glucose oxidase Drugs 0.000 claims 5
- 235000019420 glucose oxidase Nutrition 0.000 claims 5
- 101710112892 Alditol oxidase Proteins 0.000 claims 3
- 108010015133 Galactose oxidase Proteins 0.000 claims 3
- 108010073450 Lactate 2-monooxygenase Proteins 0.000 claims 3
- 108010090622 glycerol oxidase Proteins 0.000 claims 3
- 108010067997 mannitol oxidase Proteins 0.000 claims 3
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 241000709661 Enterovirus Species 0.000 claims 1
- 229940100662 nasal drops Drugs 0.000 claims 1
- 239000007922 nasal spray Substances 0.000 claims 1
- 229940097496 nasal spray Drugs 0.000 claims 1
- 201000009240 nasopharyngitis Diseases 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0800658 | 2008-03-20 | ||
| SE0800658-7 | 2008-03-20 | ||
| PCT/SE2009/050291 WO2009116944A1 (en) | 2008-03-20 | 2009-03-20 | Use of a substance for manufacturing of a medicament for treatment of common cold |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011515391A JP2011515391A (ja) | 2011-05-19 |
| JP2011515391A5 true JP2011515391A5 (enExample) | 2012-04-05 |
| JP5558458B2 JP5558458B2 (ja) | 2014-07-23 |
Family
ID=41091160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011500740A Expired - Fee Related JP5558458B2 (ja) | 2008-03-20 | 2009-03-20 | 普通感冒の治療用の医薬の製造における物質の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8895282B2 (enExample) |
| EP (1) | EP2276505B1 (enExample) |
| JP (1) | JP5558458B2 (enExample) |
| CN (1) | CN101977625A (enExample) |
| DK (1) | DK2276505T3 (enExample) |
| ES (1) | ES2436037T3 (enExample) |
| PL (1) | PL2276505T3 (enExample) |
| WO (1) | WO2009116944A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3245871A1 (en) | 2014-04-30 | 2017-11-22 | Matoke Holdings Limited | Antimicrobial compositions |
| US10213491B2 (en) * | 2015-05-19 | 2019-02-26 | The Penn State Research Foundation | Glucose oxidase compositions as a neonate anticonvulsant |
| US20180280483A1 (en) * | 2015-08-21 | 2018-10-04 | Morinaga Milk Industry Co., Ltd. | Agent for protecting upper respiratory tract and food or drink composition for protecting upper respiratory tract |
| CA3038590A1 (en) * | 2016-10-06 | 2018-04-12 | Matoke Holdings Limited | Antimicrobial compositions |
| GB201716986D0 (en) | 2017-10-16 | 2017-11-29 | Matoke Holdings Ltd | Antimicrobial compositions |
| CN112105378B (zh) | 2018-01-03 | 2025-03-11 | 宾夕法尼亚州研究基金会 | 作为新生儿抗惊厥药的葡萄糖氧化酶组合物 |
| CN112351766A (zh) | 2018-06-25 | 2021-02-09 | 璀昂芬制药公司 | 使用含锌的组合物抑制微生物感染的方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8702831L (sv) | 1987-07-10 | 1989-01-11 | Ewos Ab | Microbicid komposition |
| GB9002422D0 (en) | 1990-02-03 | 1990-04-04 | Boots Co Plc | Anti-microbial compositions |
| WO1992014484A1 (en) | 1991-02-21 | 1992-09-03 | Exoxemis, Inc. | Methods and compositions for the treatment of infection and control of flora |
| US5389369A (en) | 1991-02-21 | 1995-02-14 | Exoxemis, Inc. | Halo peroxidase containing compositions for killing yeast and sporular microorganisms |
| GB2285218A (en) * | 1993-12-17 | 1995-07-05 | William Elwyn Roberts | An aid to recovery from disease caused by bacteria fungi viruses and malignant cells |
| GB9406075D0 (en) | 1994-03-26 | 1994-05-18 | Boots Co Plc | Method of killing microorganisms |
| SE506529C2 (sv) | 1996-01-23 | 1997-12-22 | Semper Ab | Användning av ett laktoperoxidassystem för framställning av ett läkemedel mot Helicobacter pylori |
| CO4910145A1 (es) | 1996-10-01 | 2000-04-24 | Smithkline Beecham Corp | Uso |
| WO1999002148A1 (en) * | 1997-07-11 | 1999-01-21 | The Johns Hopkins University School Of Medicine | Nitric oxide inhibits rhinovirus infection |
| DE29723959U1 (de) | 1997-07-22 | 1999-07-22 | Zellner, Gerhard, Dr., 83435 Bad Reichenhall | Nasenspray-Flüssigkeit |
| AU7584500A (en) | 1999-09-17 | 2001-04-17 | Smithkline Beecham Corporation | Use of csaids in rhinovirus infection |
| US20040033260A1 (en) * | 1999-10-19 | 2004-02-19 | The Procter & Gamble Company | Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc |
| US6214339B1 (en) | 2000-01-12 | 2001-04-10 | Michael A. Pellico | Di-enzymatic treatment of outer ear infection in dogs and cats |
| AR030753A1 (es) | 2000-09-25 | 2003-09-03 | Smithkline Beecham Corp | Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas |
| SE0200876L (sv) | 2002-03-22 | 2003-09-23 | Krister Tano | Nässpray mot öroninflammationer |
| CN1408358A (zh) * | 2002-09-20 | 2003-04-09 | 高艺歌 | 一种葡萄糖酸锌(胶体)喷鼻剂的处方组成 |
| US7968122B2 (en) * | 2003-12-10 | 2011-06-28 | Adventrx Pharmaceuticals, Inc. | Anti-viral pharmaceutical compositions |
| WO2005113026A2 (en) | 2004-04-22 | 2005-12-01 | Medical Discoveries, Inc. | Method of treating respiratory disorders and airway inflammation |
| US20070026085A1 (en) | 2005-07-26 | 2007-02-01 | Global Life Technologies Corp. | Antimicrobial and antiviral composition |
| BRPI0617481A2 (pt) | 2005-10-21 | 2011-07-26 | Danisco | composiÇço que compreende um sistema enzimÁtico acoplado |
-
2009
- 2009-03-20 ES ES09721305T patent/ES2436037T3/es active Active
- 2009-03-20 CN CN2009801100377A patent/CN101977625A/zh active Pending
- 2009-03-20 DK DK09721305.2T patent/DK2276505T3/da active
- 2009-03-20 EP EP09721305.2A patent/EP2276505B1/en not_active Not-in-force
- 2009-03-20 US US12/933,438 patent/US8895282B2/en not_active Expired - Fee Related
- 2009-03-20 JP JP2011500740A patent/JP5558458B2/ja not_active Expired - Fee Related
- 2009-03-20 WO PCT/SE2009/050291 patent/WO2009116944A1/en not_active Ceased
- 2009-03-20 PL PL09721305T patent/PL2276505T3/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011515391A5 (enExample) | ||
| NL300874I2 (nl) | Elosulfase alfa | |
| JP2012530141A5 (enExample) | ||
| MX2011008416A (es) | Medicaciones antidiabeticas que comprenden un inhibidor de dpp-4 (linagliptina) opcionalmente en combinacion con otros antidiabeticos. | |
| NZ593823A (en) | Compositions and methods for the treatment or the prevention of infections by e. coli | |
| NZ599298A (en) | Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin | |
| WO2011017484A3 (en) | Sublingual and buccal film compositions | |
| PH12013500808A1 (en) | Pharmaceutical combinations for the treatment of metabolic disorders | |
| JP2010535786A5 (enExample) | ||
| NZ587060A (en) | Rna interference for the treatment of heart failure | |
| JP2015514778A5 (enExample) | ||
| JP2014501492A5 (enExample) | ||
| GB2476202A (en) | Novel choline cocrystal of epalrestat | |
| JP2012517449A5 (enExample) | ||
| Schreml et al. | A new star on the H2O2rizon of wound healing? | |
| MX2007006284A (es) | Acidos biariloximetilarenocarboxilicos. | |
| JP2013540803A5 (enExample) | ||
| WO2008111956A3 (en) | Fatty acid oxidation inhibitors treating hyperglycemia and related disorders | |
| NZ595364A (en) | TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC beta-CELL DYSFUNCTION | |
| MX357507B (es) | Metodos para tratar hiperucemia en pacientes con gota utilizando halofenato o acido halofenico y un segundo agente de reduccion de urato. | |
| JP2012525422A5 (enExample) | ||
| NZ588927A (en) | Substituted 1,3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions | |
| WO2011061554A3 (en) | Pharmaceutical composition for the treatment of bladder disorders | |
| CN201969076U (zh) | 带壳聚糖的改性聚乳酸抗粘连生物膜 | |
| CN201727562U (zh) | 纳米针刀 |